Institutional investors purchased a net $6.7 million shares of NVO during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 8.79% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACKSON SQUARE PARTNERS LLC Bought 425.8 Thousand shares of Novo Nordisk A/S
FISHER ASSET MANAGEMENT LLC Bought 109.6 Thousand shares of Novo Nordisk A/S
DOUGLAS C. LANE & ASSOCIATES, IN... Bought 90.5 Thousand shares of Novo Nordisk A/S